COST - The European Collaboration Platform for Researchers

The European Cooperation Programme for Science and Technology (known by its acronym COST) is a program that enables the creation of interdisciplinary research networks. Under the Programme, a researcher can initiate a project, which will then be joined by interested people from different countries. The program is open to representatives of various fields of science and people at different stages of a scientific career. What counts is an original and innovative idea.
You can join the Programme in three ways:
- by joining an existing COST Action,
- by participating in a Call for a new COST Action,
- becoming a COST External Expert.
Visit the COST website to learn more about COST Actions in progress and to learn more about participation.

What's new in Horizon Europe?

A series of Horizon Europe Info Days 2021 webinars organised by the European Commission will start on 28 June. Each of them will be dedicated to one cluster or news in the Programme. This will be a good opportunity for potential applicants to update themselves on the main funding instruments and processes of Horizon Europe.
One of the planned webinars, which will take place on 2 July, will be dedicated to Cluster 1 - HEALTH.
Detailed information and registration form are available on the event website
Graphical support for scientists
Biorender is a program that allows you to create professional illustrations and graphs for presenting scientific data. It contains thousands of ready-made icons and templates from many scientific fields. It is an intuitive and helpful tool when working on scientific articles.
If you are interested in taking advantage of a temporary subscription to the program, which allows you to use graphics in published texts, please contact the Center for Publication Excellence, which operates within the IDUB Program Office.
Cooperation with Industry - Course for Young Scientists

We remind you that registration for the From Scientists to Innovators for Industry program is open until June 30. This three-month course consisting of online modules, seminars, mentoring sessions, and events is addressed to Ph.D. students and young scientists interested in starting a career in industry or establishing cooperation with industry as part of their research. Registration can be done on the project website.
Open grant competitions
MINIATURE competition for funding of individual scientific activities aimed at preparation of future research project


Stanisław Ulam Programme for inviting researchers from abroad, including Polish scientists working permanently abroad (only till June 15!)
Meetings in Priority Research Areas

Team meeting #7 PRA 1 Physical and clinical aspects of radiotherapy will be held on May 20 at 2:00 pm.
For those interested in attending, please contact the coordinators of Research Team #7.
Recommended publications
A special issue of Translational Lung Cancer Research (IF 5.1), dedicated to radiation therapy of thoracic cancer, has been published, edited by Prof. Jacek Jassem and Prof. Rafał Dziadziuszko.
We encourage you to read the articles published in the issue, which are available at the following website
Recommended publications

Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells, Bilska Bernadetta, Schedel Fiona, PIOTROWSKA ANNA, Stefan Joanna, ŻMIJEWSKI MICHAŁ, Pyza Elżbieta, Reiter Russel J., Steinbrink Kerstin, Slominski Andrzej T., Tulic Meri K., Kleszczyński Konrad, Journal of Pineal Research, 2021, 70 (3).

Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer, DZIADZIUSZKO RAFAŁ, Krebs Matthew G., de Braud Filippo, Siena Salvatore, Drilon Alexander, Doebele Robert C., Patel Manish R., Cho Byoung Chul, Liu Stephen V., Ahn Myung-Ju, Chiu Chao-Hua, Farago Anna F., Lin Chia-Chi, Karapetis Christos S., Li Yu-Chung, Day Bann-mo, Chen David, Wilson Timothy R., Barlesi Fabrice, Journal of Clinical Oncology, 2021, 39 (11), 1253-1263.

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer, Golden Emily, Rashwan Rabab, Woodward Eleanor A., Sgro Agustin, Wang Edina, Sorolla Anabel, Waryah Charlene, Tie Wan Jun, Cuyas Elisabet, RATAJSKA MAGDALENA, KARDAŚ IWONA, Kozlowski Piotr, Johnstone Elizabeth K. M., See Heng B., Duffy Ciara, Parry Jeremy, Lagerborg Kim A., CZAPIEWSKI PIOTR, Menendez Javier A., GORCZYŃSKI ADAM, WASĄG BARTOSZ, Pfleger Kevin D. G., Curtis Christina, Lee Bum-Kyu, Kim Jonghwan, Cursons Joseph, Pavlos Nathan J., BIERNAT WOJCIECH, Jain Mohit, Woo Andrew J., Redfern Andrew, Blancafort Pilar, Nature Communications, 2021, 12 (1), 1920.
Copyright © Medical University of Gdańsk, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.